Clonal Hematopoiesis Clinical Trials

12 recruitingLast updated: June 18, 2026

There are 12 actively recruiting clonal hematopoiesis clinical trials across 6 countries. Studies span Not Applicable. Top locations include Seattle, Washington, United States, Atlanta, Georgia, United States, Baltimore, Maryland, United States. Updated daily from ClinicalTrials.gov.


Clonal Hematopoiesis Trials at a Glance

12 actively recruiting trials for clonal hematopoiesis are listed on ClinicalTrialsFinder across 6 cities in 6 countries. The largest study group is Not Applicable with 3 trials, with the heaviest enrollment activity in Seattle, Atlanta, and Baltimore. Lead sponsors running clonal hematopoiesis studies include Clinical Hub for Interventional Research (CHOIR), Dana-Farber Cancer Institute, and Children's Oncology Group.

Browse clonal hematopoiesis trials by phase

Treatments under study

About Clonal Hematopoiesis Clinical Trials

Looking for clinical trials for Clonal Hematopoiesis? There are currently 7 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Clonal Hematopoiesis trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Clonal Hematopoiesis clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 112 of 12 trials

Recruiting

CHIP/CCUS Natural History Protocol

Clonal Cytopenia of Undetermined SignificanceClonal Hematopoiesis of Indeterminate Potential
National Heart, Lung, and Blood Institute (NHLBI)306 enrolled1 locationNCT04102423
Recruiting
Not Applicable

A Dietary Study for People With Clonal Hematopoiesis

Clonal Hematopoiesis
Memorial Sloan Kettering Cancer Center36 enrolled7 locationsNCT07590804
Recruiting

CHAPTER: Clonal Haematopoiesis Assessment: Prevention, Treatment and Research

Clonal HematopoiesisHematologic Disease and DisordersCCUS Clonal Cytopenia of Undetermined Significance
Clinical Hub for Interventional Research (CHOIR)100 enrolled1 locationNCT07313059
Recruiting

A Study About How Blood Cell Growth Patterns Relate to Heart Health After Treatment for Hodgkin Lymphoma

Classic Hodgkin LymphomaCardiovascular DisorderClonal Hematopoiesis
Children's Oncology Group190 enrolled32 locationsNCT05705531
Recruiting

Clonal Hematopoiesis and Therapy-Emergent Myeloid Neoplasms in Patients With Cancers, CHANCES Study

Ovarian CarcinomaRecurrent Ovarian CarcinomaRecurrent Malignant Solid Neoplasm+7 more
University of Washington2,000 enrolled1 locationNCT06295965
Recruiting

Pre-malignant States to Hematologic Malignancies in Firefighters

Non-Hodgkin LymphomaMultiple MyelomaLeukemia+3 more
Wake Forest University Health Sciences300 enrolled1 locationNCT06870760
Recruiting

Metabolic Profiling of Hematopoietic Stem Cells in Clonal Hematopoiesis (CHIP)

OsteoporosisHip FracturesAging+2 more
Imelda Hospital, Bonheiden24 enrolled1 locationNCT05246813
Recruiting

Li-Fraumeni & TP53 (LiFT UP): Understanding and Progress

Hereditary Cancer SyndromeLi-Fraumeni SyndromeTP53 Gene Mutation+2 more
Dana-Farber Cancer Institute1,500 enrolled3 locationsNCT04541654
Recruiting
Not Applicable

Pre-myeloid Cancer and Bone Marrow Failure Clinic Study

Hematopoietic and Lymphatic System NeoplasmHematologic NeoplasmsMyeloid Malignancy+10 more
Mayo Clinic2,000 enrolled3 locationsNCT02958462
Recruiting
Not Applicable

Clonal Hematopoiesis and NETs Formation in Venous Thrombosis (CLODETTE)

Clonal Hematopoiesis of Indeterminate PotentialVenous ThrombosesThromboembolic Disease+1 more
University Hospital, Bordeaux150 enrolled7 locationsNCT05711173
Recruiting

The Clonal Hematopoiesis & Inflammation in Vasculature Registry and Biorepository

Clonal Hematopoiesis
Vanderbilt-Ingram Cancer Center800 enrolled1 locationNCT06701214
Recruiting

Donor CHIP and Allogeneic HSCT Outcome

Clonal Hematopoiesis
The University of Hong Kong850 enrolled1 locationNCT04689750